Cyclacel Pharmaceuticals Announces Stock Split
Cyclacel Pharmaceuticals Announces Stock Split GlobeNewswire July 02, 2025 BERKELEY HEIGHTS, N.J., July 02, 2025 (GLOBE NEWSWIRE) — Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; “Cyclacel” or the “Company”), a biopharmaceutical company developing innovative medicines, today announced that it expects to implement a 1-for-15 reverse stock split on its shares of common stock effective July […]